Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): Towards slowing the macular ageing process

Experimental Eye Research

Volumn 97, Issue 1, 2012, Pages 63-72

  Treumer, F ^a   Klettner, A ^a   Baltz, J ^a   Hussain, A A ^b   Miura, Y ^c   Brinkmann, R ^c   Roider, J ^a   Hillenkamp, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Age related macular degeneration; Bruch's membrane; Matrix metalloproteinases; Retinal pigment epithelium; Selective retina therapy

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CHOROID; ENZYME RELEASE; EXPLANT; LOW LEVEL LASER THERAPY; MONOLAYER CULTURE; NEODYMIUM LASER; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SELECTIVE RETINA THERAPY; SWINE; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; CELL DEATH; CELL SURVIVAL; CHOROID; DIFFUSION CHAMBERS, CULTURE; FLUORESCEINS; LASER THERAPY; LASERS, SOLID-STATE; MACULAR DEGENERATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; ORGAN CULTURE TECHNIQUES; RETINAL PIGMENT EPITHELIUM; SENSORY THRESHOLDS; SWINE; WOUND HEALING;

EID: 84859508530     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.02.011     Document Type: Article

References (65)

1. Ahir A., Guo L., Hussain A.A., Marshall J. Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 2002, 43:458-465.
2. Alcazar O., Cousins S.W., Marin-Castano M.E. MMP-14 and TIMP-2 overexpression protects against hydroquinone-induced oxidant injury in RPE: implications for extracellular matrix turnover. Invest. Ophthalmol. Vis. Sci. 2007, 48:5662-5670.
3. Alexander J.P., Bradley J.M., Gabourel J.D., Acott T.S. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1990, 31:2520-2528.
4. Amin S., Chong N.H., Bailey T.A., Zhang J., Knupp C., Cheetham M.E., Greenwood J., Luthert P.J. Modulation of Sub-RPE deposits in vitro: a potential model for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2004, 45:1281-1288.
5. Brinkmann R., Huttmann G., Rogener J., Roider J., Birngruber R., Lin C.P. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg. Med. 2000, 27:451-464.
6. Brinkmann R., Roider J., Birngruber R. Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results. Bull. Soc. Belge. Ophtalmol. 2006, 302:51-69.
7. Bussolati O., Belletti S., Uggeri J., Gatti R., Orlandini G., Dall'Asta V., Gazzola G.C. Characterization of apoptotic phenomena induced by treatment with L-asparaginase in NIH3T3 cells. Exp. Cell Res. 1995, 220:283-291.
8. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., Schade van Westrum S., Crabbe T., Clements J., d'Ortho M.P., Murphy G. The TIMP-2 membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A: a kinetic study. J. Biol. Chem. 1998, 273:871-880.
9. Del Priore L.V., Glaser B.M., Quigley H.A., Green W.R. Response of pig retinal pigment epithelium to laser photocoagulation in organ culture. Arch. Ophthalmol. 1989, 107:119-122.
10. Della N.G., Campochiaro P.A., Zack D.J. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1996, 37:1921-1924.
11. Fariss R.N., Apte S.S., Olsen B.R., Iwata K., Milam A.H. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am. J. Pathol. 1997, 15:323-328.
12. Flaxel C., Bradle J., Acott T., Samples J.R. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 2007, 27:629-634.
13. Friberg T.R., Brennen P.M., Freeman W.R., Musch D.C. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surg. Lasers Imaging 2009, 40:530-538.
14. Guo L., Hussain A.A., Limb G.A., Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest. Ophthalmol. Vis. Sci. 1999, 40:2676-2682.
15. Hamlin C.R., Kohn R.R. Evidence for progressive, age-related structural changes in post-mature human collagen. Biochim. Biophys. Acta 1971, 236:458-467.
16. Hammes H.P., Hoerauf H., Alt A., Schleicher E., Clausen J.T., Bretzel R.G., Laqua H. N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1999, 40:1855-1859.
17. Handa J.T., Verzijl N., Matsunaga H., Aotaki-Keen A., Lutty G.A., te Koppele J.M., Miyata T., Hjelmeland L.M. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest. Ophthalmol. Vis. Sci. 1999, 40:775-779.
18. Hergott G.J., Kalnins V.I. Expression of proliferating cell nuclear antigen in migrating retinal pigment epithelial cells during wound healing in organ culture. Exp. Cell Res. 1991, 195:307-314.
19. Hillenkamp J., Hussain A.A., Jackson T.L., Cunningham J.R., Marshall J. The influence of path length and matrix components on ageing characteristics of transport between the choroid and the outer retina. Invest. Ophthalmol. Vis. Sci. 2004, 45:1493-1498.
20. Hillenkamp J., Hussain A.A., Jackson T.L., Cunningham J.R., Marshall J. Taurine uptake by human retinal pigment epithelium: implications for the transport of small solutes between the choroid and the outer retina. Invest. Ophthalmol. Vis. Sci. 2004, 45:4529-4534.
21. Ho A.C., Maguire M.G., Yoken J., Lee M.S., Shin D.S., Javornik N.B., Fine S.L. Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 1999, 106:1367-1373.
22. Hollborn M., Stathopoulos C., Steffen A., Wiedemann P., Kohen L., Bringmann A. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:4360-4367.
23. Holz F.G., Sheraidah G., Pauleikhoff D., Bird A.C. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch. Ophthalmol. 1994, 112:402-406.
24. Hunt R.C., Fox A., al P.,V., Sigel M.M., Kosnosky W., Choudhury P., Black E.P. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest. Ophthalmol. Vis. Sci. 1993, 34:3179-3186.
25. Hussain A.A., Lee Y., Marshall J. High molecular-weight gelatinase species of human Bruch's membrane: compositional analyses and age-related changes. Invest. Ophthalmol. Vis. Sci. 2010, 51:2363-2371.
26. Hussain A.A., Starita C., Hodgetts A., Marshall J. Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD). Exp. Eye Res. 2010, 90:703-710.
27. Hussain A.A., Lee Y., Zhang J.J., Marshall J. Disturbed matrix metalloproteinase (MMP) activity of Bruch's membrane in age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2011, 52(7):4459-4466.
28. Irschick E.U., Haas G., Troger J., Ueberall F., Huemer H.P. Involvement of protein kinase C in phagocytosis of human retinal pigment epithelial cells and induction of matrix metalloproteinase secretion. Int. Ophthalmol. 2009, 29:333-341.
29. Ishibashi T., Murata T., Hangai M., Nagai R., Horiuchi S., Lopez P.F., Hinton D.R., Ryan S.J. Advanced glycation end products in age-related macular degeneration. Arch. Ophthalmol. 1998, 116(12):1629-1632.
30. Kamei M., Hollyfield J.G. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1999, 40(10):2367-2375.
31. Karwatowski W.S., Jeffries T.E., Duance V.C., Albon J., Bailey A.J., Easty D.L. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br. J. Ophthalmol. 1995, 79:944-952.
32. Kiilgaard J.F., Prause J.U., Prause M., Scherfig E., Nissen M.H., la Cour M. Subretinal posterior pole injury induces selective proliferation of RPE cells in the periphery in in vivo studies in pigs. Invest. Ophthalmol. Vis. Sci. 2007, 48:355-360.
33. Kim C.H., Lee J.H., Won J.H., Cho M.K. Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor. J. Korean Med. Sci. 2011, 26:726-733.
34. Kumar A., El Osta A., Hussain A.A., Marshall J. Increased sequestration of matrix metalloproteinases in ageing human Bruch's membrane: implications for ECM turnover. Invest. Ophthalmol. Vis. Sci. 2010, 51:2664-2670.
35. Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M., Racik J.M. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am. J. Pathol. 2002, 161:1247-1253.
36. Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noël A., Rakic J.M. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 2003, 17:2290-2292.
37. Lee J.Y., Kim H.S., Oh T.H., Yune T.Y. Ethanol extract of Bupleurum falcatum improves functional recovery by inhibiting matrix metalloproteinases-2 and -9 activation and inflammation after spinal cord injury. Exp. Neurobiol. 2010, 19:146-154.
38. Maguire M.G., Ying G.-S., Alexander J., Browning D.J., Peskin E., Folk J.C., Antoszyk A.N., Grunwald J.E., Klein M.L., Lyon A., McCannel C.A., Stoltz R.A., Trese M., Fine S.L. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Ophthalmology 2006, 113:1974-1986.
39. Marin-Castano M.E., Csaky K.G., Cousins S.W. Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity. Invest. Ophthalmol. Vis. Sci. 2005, 46:3331-3340.
40. Marin-Castano M.E., Striker G.E., Alcazar O., Catanuto P., Espinosa-Heidmann D.G., Cousins S.W. Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest. Ophthalmol. Vis. Sci. 2006, 47:4098-4112.
41. Miura Y., Klettner A., Noelle B., Hasselbach H., Roider J. Change of morphological and functional characteristics of retinal pigment epithelium cells during cultivation of retinal pigment epithelium-choroid perfusion tissue culture. Ophthalmic Res. 2010, 43:122-133.
42. Mojana F., Brar M., Cheng L., Bartsch D.U., Freeman W.R. Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen. Retina 2011, 31:235-242.
43. Moore D.J., Clover G.M. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest. Ophthalmol. Vis. Sci 2001, 42:2970-2975.
44. Moore D.J., Hussain A.A., Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 1995, 36:1290-1297.
45. Mott J.D., Khalifah R.G., Nagase H., Shield C.F., Hudson J.K., Hudson B.G. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int. 1997, 52:1302-1312.
46. Nagai N., Klimava A., Lee W.H., Izumi-Nagai K., Handa J.T. CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways. Invest. Ophthalmol. Vis. Sci. 2009, 50:1903-1910.
47. Okubo A., Rosa R.H., Bunce C.V., Alexander R.A., Fan J.T., Bird A.C., Luthert P.J. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 1999, 40:443-449.
48. Owens S.L., Bunce C., Brannon A.J., Xing W., Chisholm I.H., Gross M., Guymer R.H., Holz F.G., Bird A.C. Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am. J. Ophthalmol. 2006, 141:276-281.
49. Palma P.F., Baggio G.L., Spada C., Silva R.D., Ferreira S.I., Treitinger A. Evaluation of annexin V and Calcein-AM as markers of mononuclear cell apoptosis during human immunodeficiency virus infection. Braz. J. Infect. Dis. 2008, 12:108-114.
50. Pauleikhoff D., Zuels S., Sheraidah G.S., Marshall J., Wessing A., Bird A.C. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology 1992, 99:1548-1553.
51. Ramrattan R.S., van der Schaft T.L., Mooy C.M., de Bruijn W.C., Mulder P.G., de Jong P.T. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest. Ophthalmol. Vis. Sci. 1994, 35:2857-2864.
52. Rodanant N., Friberg T.R., Cheng L., Aurora A., Bartsch D., Toyoguchi M., Corbin P.S., El-Bradey M.H., Freeman W.R. Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. Am. J. Ophthalmol. 2002, 134:577-585.
53. Roider J., Michaud N.A., Flotte T.J., Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation. Arch. Ophthalmol. 1992, 110:1786-1792.
54. Roider J., Michaud N., Flotte T., Birngruber R. Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium. Ophthalmologe 1993, 90:274-278.
55. Roider J., Hillenkamp F., Flotte T., Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc. Natl. Acad. Sci. U S A 1993, 90:8643-8647.
56. Roider J., Brinkmann R., Wirbelauer C., Laqua H., Birngruber R. Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch. Ophthalmol. 1999, 117:1028-1034.
57. Roider J., Brinkmann R., Wirbelauer C., Laqua H., Birngruber R. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br. J. Ophthalmol. 2000, 84:40-47.
58. Schuele G., Elsner H., Framme C., Roider J., Birngruber R., Brinkmann R. Optoacoustic real-time dosimetry for selective retina treatment. J. Biomed. Opt. 2005, 10:064022.
59. Starita C., Hussain A.A., Pagliarini S., Marshall J. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp. Eye Res. 1996, 62:565-572.
60. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J. Biol. Chem. 1995, 270:5331-5338.
61. Vater C.A., Harris E.D., Siegel R.C. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem. J. 1979, 181:639-645.
62. von Leithner P.L., Ciurtin C., Jeffery G. Microscopic mammalian retinal pigment epithelium lesions induce widespread proliferation with differences in magnitude between center and periphery. Mol. Vis. 2010, 16:570-581.
63. Vranka J.A., Johnson E., Zhu X., Shepardson A., Alexander J.P., Bradley J.M., Wirtz M.K., Weleber R.G., Klein M.L., Acott T.S. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr. Eye Res. 1997, 16:102-110.
64. Yamada Y., Ishibashi K., Bhutto I.A., Tian J., Lutty G.A., Handa J.T. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp. Eye Res. 2006, 82:840-848.
65. Zhou J., Zhang J., Chao J. Porphyromonas gingivalis promotes monocyte migration by activating MMP-9. J. Periodontal Res. 2011, [Epub ahead of print]. 10.1111/j.1600-0765.2011.01427.x.